Hybrid Postdoctoral Scholar - Clinical Translational Scientist bei Precede

Our team is dedicated to the development of advanced, non-invasive diagnostics to inform the care of patients with cancer and other diseases. We care deeply about creating a place where folks can do their best work from the start. This means enjoying camaraderie and challenges as a team. This means solving hard problems and troubleshooting together. Our ideal teammate thrives when working side by side with crossfunctional colleagues. Our company was founded in 2021, backed by 5AM Ventures through its 4:59 Initiative incubator engine. We are based in the vibrant Seaport district of Boston.

This is a newly established role in close collaboration with Dana-Farber Cancer Institute (DFCI), designed to accelerate our efforts in understanding and overcoming therapeutic resistance in breast and gynecologic cancers. This position offers a unique opportunity to work at the intersection of academic rigor and translational application, embedded within a dynamic biotech environment and supported by DFCI’s clinical and scientific excellence. As a Postdoctoral Scholar, you’ll be encouraged to lead independent research projects that result in high-impact publications and shape future diagnostic approaches. You will be embedded within our translational science team and work cross-functionally across research, computational biology and external collaborations. The postdoc will be encouraged to lead independent projects resulting in high impact publications, present at conferences and prepare for long-term careers in academia or industry.

The minimum base salary for this position is $72,000. Compensation is based on the number of months of relevant postdoctoral experience the successful candidate brings to the role. Please note that the base salary is fixed and not subject to negotiation.